|
PARP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.636400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.900700E-03 |
| Normal-vs-Stage2 |
4.001700E-02 |
| Normal-vs-Stage3 |
2.608200E-01 |
| Normal-vs-Stage4 |
6.134800E-01 |
| Stage1-vs-Stage2 |
3.197400E-01 |
| Stage1-vs-Stage3 |
6.987400E-01 |
| Stage1-vs-Stage4 |
9.379000E-03 |
| Stage2-vs-Stage3 |
3.237800E-01 |
| Stage2-vs-Stage4 |
2.513800E-02 |
| Stage3-vs-Stage4 |
1.643650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.164260E-03 |
| Normal-vs-AfricanAmerican |
5.090000E-02 |
| Normal-vs-Asian |
9.176000E-01 |
| Caucasian-vs-AfricanAmerican |
5.410200E-01 |
| Caucasian-vs-Asian |
3.503600E-01 |
| AfricanAmerican-vs-Asian |
4.206400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.643500E-03 |
| Normal-vs-Female |
5.855100E-03 |
| Male-vs-Female |
5.087600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.225600E-01 |
| Normal-vs-Extreme_Weight |
1.600010E-01 |
| Normal-vs-Obese |
1.138490E-03 |
| Normal-vs-Extreme_Obese |
7.330800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.121800E-01 |
| Normal_Weight-vs-Obese |
6.464400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.882000E-01 |
| Extreme_Weight-vs-Obese |
2.985800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.246800E-01 |
| Obese-vs-Extreme_Obese |
2.395200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.228200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.76500000000002E-05 |
| Normal-vs-Age(61-80Yrs) |
3.770100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.794800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.075800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.824800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.061400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.535640E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.374200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.828800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.227500E-04 |
| Normal-VS-Type2 PRCC |
1.609040E-01 |
| Normal-VS-KIRP CIMP |
2.795200E-01 |
| Normal-VS-Unclassified PRCC |
4.495700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.047200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.046000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.656390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.586300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.991500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.002070E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.629000E-01 |
| Normal-vs-N1 |
1.983390E-01 |
| Normal-vs-N2 |
2.306500E-02 |
| N0-vs-N1 |
4.007000E-01 |
| N0-vs-N2 |
4.04370000000043E-05 |
| N1-vs-N2 |
4.151200E-04 |
|
|
